Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hello! It’s Meghana. Today, we learn that Verve Therapeutics is pausing the testing of its PCSK9-focused gene editing treatment. The FDA approves the first digital therapeutic from a pharma company, and we have a new biotech scoreboard for you.
Click this link for the original source of this article.
Author: Meghana Keshavan
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.